Low-Molecular-Weight Heparins: Do Good Things Really Come in Small Packages?

McLane J . The thromboplastic action of cephalin. Am J Physiol 1916; 41: 250–7.

Petitou M Duchaussoy P Lederman K Choay J . Binding of heparin to antithrombin III. Chemical proof of the role played by a 3-sulfated 2-amino-deoxy-D-glucose residue. Carbohydr Res 1988; 179: 163–72.

Verstraete M . Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 1990; 40: 498–530.

Andersson LO Barrowcliffe TW Holmer E Johnson EA Sims GEC . Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575–83.

Kandrotas RJ . Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992; 22: 359–74.

Henny CP ten Cate H ten Cate JW Moulijn AC Sie TH Warren P . A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. J Lab Clin Med 1985; 106: 187–96.

Hobbelen PM Vogel GM Meuleman DG . Time courses of antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid ORG 10172 or heparin to rats. Thromb Res 1987; 48: 549–58.

Bergqvist D Nilsson B Hedner U Pedersen PC Ostergaard PB . The effect of heparin fragments of different molecular weights on experimental thrombosis and hemostasis. Thromb Res 1985; 38: 589–601.

Kandrotas RJ Gal P Douglas JB Deterding J . Heparin pharmacokinetics during hemodialysis. Ther Drug Monit 1989; 11: 674–9.

Boneu B Caranobe C Gabaig AM DuPouy D Sie P Buchanan MR . Evidence for a saturable mechanism of disappearance of standard heparin in rabbits. Thromb Res 1987; 46: 835–44.

Boneu B Buchanan MR Cade JF van Ryn J Fernandez FP Ofosu FA . Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo. Thromb Res 1985; 40: 81–9.

Ockelford PA Carter CJ Mitchell L Hirsh J . Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction. Thomb Res 1982; 28: 401–9.

Buchanan MR Boneu B Ofosu F Hirsh J . The relative importance of thrombin inhibition to the antithrombotic effects of heparin. Blood 1985; 65: 198–201.

Barrowcliffe TW . Heparin assays and standardization. In: Lane DA Lindahl U , eds. Heparin: Chemical and biological properties, clinical applications. Boca Raton, FL: CRC Press, 1989: 393–415.